Showing results (5441-5450 of 5,703) with videos related to

Sort By:
Pageof 571
The Oncologist|November 6, 2009
A case of advanced medullary thyroid carcinoma successfully treated with sunitinibMaria João Bugalho, Rita Domingues, Alexandra Borges
The Oncologist|April 7, 2018
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release SyndromeRobert Q Le, Liang Li, Weishi Yuan, et al.
The Oncologist|July 9, 2017
Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III TrialSe-Il Go, Dong-Hoe Koo, Seung Tae Kim, et al.
The Oncologist|April 19, 2018
Delayed Autoimmune Toxicity Occurring Several Months After Cessation of Anti-PD-1 TherapySagun Parakh, Jonathan Cebon, Oliver Klein
The Oncologist|April 21, 2018
Lenalidomide in Pretreated Mantle Cell Lymphoma Patients: An Italian Observational Multicenter Retrospective Study in Daily Clinical Practice (the Lenamant Study)Vittorio Stefoni, Cinzia Pellegrini, Alessandro Broccoli, et al.
The Oncologist|April 14, 2018
Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors for Central Nervous System Metastases from Non-Small Cell Lung CancerManmeet S Ahluwalia, Kevin Becker, Benjamin P Levy
The Oncologist|April 14, 2018
Use of Direct Oral Anticoagulants in Patients with Cancer: Practical Considerations for the Management of Patients with Nausea or VomitingHanno Riess, Cihan Ay, Rupert Bauersachs, et al.
The Oncologist|June 6, 2018
Comparative Molecular Analyses of Esophageal Squamous Cell Carcinoma, Esophageal Adenocarcinoma, and Gastric AdenocarcinomaMohamed E Salem, Alberto Puccini, Joanne Xiu, et al.
The Oncologist|June 2, 2018
A Phase I Study of Ganetespib and Ziv-Aflibercept in Patients with Advanced Carcinomas and SarcomasRobert Meehan, Shivaani Kummar, Khanh Do, et al.
The Oncologist|June 24, 2018
Endocrine Therapy in Premenopausal Hormone Receptor Positive/Human Epidermal Growth Receptor 2 Negative Metastatic Breast Cancer: Between Guidelines and LiteratureRichard Tancredi, Jenny Furlanetto, Sibylle Loibl
Pageof 571